Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis

Monitoring of atrial fibrillation in primary care patients prescribed direct oral anticoagulants for stroke prevention

(2020) Aileen Murphy et al.   IRISH JOURNAL OF MEDICAL SCIENCE

Clinicians’ views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis

(2020) Ruth V. Pritchett et al.   PLoS One

Direct oral anticoagulants uptake and an oral anticoagulation paradox

(2019) Cormac Kennedy et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study

(2018) John K. Bartoli- Abdou et al.   THROMBOSIS RESEARCH

A survey of reasons for continuing warfarin therapy in the era of direct oral anticoagulants in Japanese patients with atrial fibrillation: the SELECT study

(2018) Takanori Ikeda et al.   Patient Preference and Adherence

A systematic review of clinicians' views and experiences of direct-acting oral anticoagulants in the management of nonvalvular atrial fibrillation

(2018) Daria Generalova et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives

(2017) Caleb Ferguson et al.   JOURNAL OF CLINICAL NURSING

Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study

(2017) Danielle E Clarkesmith et al.   THROMBOSIS RESEARCH

Anticoagulation in atrial fibrillation: NOAC prescribing in primary health care

(2017) Carla Bastida et al.   International Journal of Clinical Pharmacy

How do family medicine residents choose an anticoagulation regimen for patients with nonvalvular atrial fibrillation?

(2017) Payam Yazdan-Ashoori et al.   Primary Health Care Research and Development

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data

(2017) Joshua D. Brown et al.   Journal of Managed Care & Specialty Pharmacy

Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation

(2016) Mark H. Eckman et al.   AMERICAN HEART JOURNAL

A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras

(2016) Joshua D. Brown et al.   DRUGS & AGING

Multi-morbidity, frailty and self-care: important considerations in treatment with anticoagulation drugs. Outcomes of the AFASTER study

(2016) Caleb Ferguson et al.   European Journal of Cardiovascular Nursing

Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke

(2016) Emer R. McGrath et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation

(2016) G. Bertozzo et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals’ views

(2016) Yishen Wang et al.   International Journal of Clinical Pharmacy

To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort

(2015) Serena Granziera et al.   Internal and Emergency Medicine

HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement

(2015) David S. Frankel et al.   Journal of Stroke & Cerebrovascular Diseases

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study

(2015) A. Gorst-Rasmussen et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands

(2015) Susan Hanemaaijer et al.   International Journal of Clinical Pharmacy

HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement

(2015) David S. Frankel et al.   Journal of Stroke & Cerebrovascular Diseases

Comorbidities against Quality Control of VKA Therapy in Non-Valvular Atrial Fibrillation: A French National Cross-Sectional Study

(2015) Agnes Rouaud et al.   PLoS One

The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation

(2014) Terry Ann Glauser et al.   AMERICAN JOURNAL OF MEDICAL QUALITY

Appropriateness of Prescribing Dabigatran Etexilate and Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation

(2014) Anne-Sophie Larock et al.   ANNALS OF PHARMACOTHERAPY

Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives

(2014) Pablo Alonso-Coello et al.   HEALTH EXPECTATIONS

Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial

(2013) Danielle E. Clarkesmith et al.   PLoS One

Frequency and Risk Factors for Under- and Over-Treatment in Stroke Prevention for Patients with Non-Valvular Atrial Fibrillation in General Practice

(2013) Derk L. Arts et al.   PLoS One

Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy: A qualitative meta-synthesis

(2012) Christian Borg Xuereb et al.   PATIENT EDUCATION AND COUNSELING

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST